Dr. Samir Patel, MD

Dr. Patel practices at DaVita Bastanchury Dialysis in Fullerton, California.

Dr. Patel's NPI, 1427519552, was assigned on March 29, 2019. Dr. Patel graduated from Medical University of Lublin in 2015. Dr. Patel holds California license 177071.

Dr. Patel's primary practice is DaVita Bastanchury Dialysis, at 1950 Sunnycrest Drive Suite 1300, Fullerton, CA 92835 in Orange County. The practice phone is (714) 578-0015.

Dr. Patel's primary practice is DaVita Bastanchury Dialysis in Fullerton, California. Dr. Patel is also affiliated with Providence St. Jude Medical Center. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Patel to 4 more hospitals, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Patel is board certified in anesthesiology by the American Board of Anesthesiology. Dr. Patel is licensed in California.

CMS data shows 397 Medicare services from Dr. Patel across 3 procedure codes in 2024, for 126 Medicare patients. Medicare paid $31,805 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 71% are also on Medicaid. Their average risk score is 5.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 69, with 47% women.

In 2024, Dr. Patel wrote 31 Medicare Part D claims for 19 patients. 71% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $76 in total drug cost. In 2022, CMS named 18 claims across 1 drug.

Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 1 paper to Dr. Patel in 2023. Dr. Patel's most frequent co-authors are Stefan Octavian Ciurea, MD, Sheetal Ramesh Desai, MD and Ramy Magdy Hanna, MD.

CMS Open Payments shows 36 general payments to Dr. Patel from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Aurinia Pharma U.S., Inc. paid the most, $236.

Dr. Patel graduated from Medical University of Lublin in 2015.

Dr. Patel is in network with 3 carriers, including Aetna, Humana and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.